About us

ADP works to ensure that people in low- and middle-income countries have access to life-saving health technologies – medicines, vaccines and diagnostic tools – with an emphasis on those technologies that address tuberculosis, malaria and neglected tropical diseases.

The partners

ADP brings together the United Nations Development Programme (UNDP), the World Health Organization (WHO), the Special Programme for Research and Training in Tropical Diseases (TDR) and PATH in a unique partnership that helps identify and strengthen capacity gaps in low- and middle-income countries in an innovative and integrated way.

Strengthening national health systems

In line with the overarching approach of the 2030 Agenda for Sustainable Development, ADP adopts a systemic and integrated perspective towards health system strengthening, aimed at the interlinked targets of eliminating communicable and infectious diseases and achieving real progress towards universal health coverage.

Supporting national responses to COVID-19

The COVID-19 pandemic has highlighted the critical importance of ensuring equitable access to health services, as well as increasing availability of medicines, vaccines and diagnostic tools in response to established and emerging health threats.

Regional, global and
South-South cooperation

Focusing on common challenges across different health systems, ADP leverages the experiences and expertise of its network of stakeholders to deliver both policy lessons and technical solutions.

Focus countries

ADP collaborates with stakeholders in a number of focus countries – Bhutan, Burkina Faso, Ghana, India, Indonesia, Malawi, Senegal, United Republic of Tanzania and Thailand
– to implement a range of capacity-strengthening interventions, which are in line with the ADP strategic approach of leveraging the expertise of its four core partners and working across sectors to help strengthen and harmonize policies, regulations and systems, as well as build the capacities of key people and institutions.

Uniting Efforts

The global response to the COVID-19 pandemic has highlighted how close collaboration among multiple stakeholders can overcome major hurdles to the development, approval and delivery of new medicines, vaccines and diagnostic tools. But opportunities for such intense collaboration are rare, and access to new health technologies remains uneven.

Knowledge products

ADP knowledge products advance learning and contribute to improved policies, programmes and practices, as well as demonstrate human impact on the ground.

TDR Implementation research toolkit

This toolkit is designed to help teams conduct implementation research projects through a standard process to ensure reliable, high-quality results.

COVID-19 diagnostics procurement resource

An interactive tool to support procurement decisions by aggregating and streamlining publicly available information about the technical specifications, regulatory status and supply of COVID-19 diagnostic tests.

A pipeline analysis of new products for malaria, tuberculosis and neglected tropical diseases

This working paper provides a comprehensive survey of new medicines, diagnostics and vaccines for malaria, TB and selected NTDs, that are currently in the pipeline for market entry by 2020.

Digital Health for Development Hub

A one-stop shop with technical, advisory and partnership support for scaling up digital health solutions.

Strengthening national health systems

Even while tackling COVID-19, it remains vitally important to ensure that other national health priorities – such as those related to combating tuberculosis, malaria and neglected tropical diseases – are not at risk of neglect. It is crucial to adopt measures to both protect previous gains against these diseases and mitigate against any future reversals in progress towards related targets.

The Access and Delivery Partnership (ADP) is focused on addressing the most pressing and immediate health needs. Maintaining the most critical prevention activities and health care services, and minimizing disruptions during the pandemic, will also significantly reduce the indirect impacts of COVID-19, particularly among poor and marginalized populations.

ADP partners have thus adopted a two-pronged strategy: supporting national responses to the COVID-19 pandemic and continuing to bolster national health system capacities – each through the building of capacities and systems, and provision of essential technical advice and information.

Strengthened institutional and technical capacities help drive access to and delivery of affordable and quality assured medicines, vaccines and diagnostic tools. This approach is in line with the overarching ADP goals and underscores the relevance of the specific focus of ADP on strengthening national health systems and their preparedness for health technology introduction.

Since its inception in 2013, ADP has supported governments and national stakeholders to strengthen health systems. This encompasses the promotion of key policies, processes and capacities along the value chain of access and delivery – from enabling policy and regulatory frameworks, to digital health and data management, implementation research, regulatory authorization, procurement and supply chain management, ultimately extending to service delivery and patient safety monitoring. Such a whole-of-government approach is also an essential element of coordinated and effective COVID-19 responses and helps build the foundation for greater pandemic preparedness in the future.

About us

The partners